Difficulty: Medium
Average Score: 90%
Practice
The therapeutic action of neurotransmitter inhibitors that block reuptake cause:
Correct answer
B
Rationale
The correct answer is B) increased concentration of the blocked neurotransmitter in the synaptic gap.
Explanation:
Neurotransmitter inhibitors that block reuptake prevent the reabsorption of neurotransmitters back into the presynaptic neuron after they have been released into the synaptic gap. This results in an increased concentration of the blocked neurotransmitter in the synaptic gap. By blocking reuptake, these medications allow the neurotransmitter to remain in the synaptic gap longer, increasing its availability to bind to postsynaptic receptors and exert its effects.
Why the other options are wrong:
A) decreased concentration of the blocked neurotransmitter in the central nervous system: This is incorrect because blocking reuptake actually leads to an increased concentration of the neurotransmitter in the synaptic gap, not a decreased concentration in the central nervous system.
C) destruction of receptor sites specific to the blocked neurotransmitter: This is incorrect because neurotransmitter inhibitors that block reuptake do not destroy receptor sites. They primarily act by interfering with the reuptake process, not by destroying receptors.
D) limbic system stimulation: This is incorrect as it is not directly related to the mechanism of action of neurotransmitter inhibitors that block reuptake. These medications work by modulating neurotransmitter levels in the synaptic gap, rather than specifically targeting the limbic system for stimulation.
Educational context:
Understanding the mechanism of action of psychotropic medications is crucial for healthcare professionals working in mental health settings. Knowledge of how neurotransmitter inhibitors that block reuptake function can help in explaining the therapeutic effects and potential side effects of these medications to patients. It also aids in making informed decisions regarding medication selection and monitoring for adverse reactions.
Explanation:
Neurotransmitter inhibitors that block reuptake prevent the reabsorption of neurotransmitters back into the presynaptic neuron after they have been released into the synaptic gap. This results in an increased concentration of the blocked neurotransmitter in the synaptic gap. By blocking reuptake, these medications allow the neurotransmitter to remain in the synaptic gap longer, increasing its availability to bind to postsynaptic receptors and exert its effects.
Why the other options are wrong:
A) decreased concentration of the blocked neurotransmitter in the central nervous system: This is incorrect because blocking reuptake actually leads to an increased concentration of the neurotransmitter in the synaptic gap, not a decreased concentration in the central nervous system.
C) destruction of receptor sites specific to the blocked neurotransmitter: This is incorrect because neurotransmitter inhibitors that block reuptake do not destroy receptor sites. They primarily act by interfering with the reuptake process, not by destroying receptors.
D) limbic system stimulation: This is incorrect as it is not directly related to the mechanism of action of neurotransmitter inhibitors that block reuptake. These medications work by modulating neurotransmitter levels in the synaptic gap, rather than specifically targeting the limbic system for stimulation.
Educational context:
Understanding the mechanism of action of psychotropic medications is crucial for healthcare professionals working in mental health settings. Knowledge of how neurotransmitter inhibitors that block reuptake function can help in explaining the therapeutic effects and potential side effects of these medications to patients. It also aids in making informed decisions regarding medication selection and monitoring for adverse reactions.